Home |
Free Dividend Report |
Stock Splits Calendar |
FATE Stock Split History |
Preferred Stock Newsletter |
FATE Options Chain |
Stock Message Boards |
Fate Therapeutics (FATE) has 0 splits in our Fate Therapeutics stock split history database.
Looking at the Fate Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Fate Therapeutics shares, starting with a $10,000 purchase of FATE, presented on a split-history-adjusted basis factoring in the complete Fate Therapeutics stock split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 05/05/2014 | |
End date: | 05/01/2024 | |
Start price/share: | $7.01 | |
End price/share: | $4.09 | |
Dividends collected/share: | $0.00 | |
Total return: | -41.65% | |
Average Annual Total Return: | -5.25% | |
Starting investment: | $10,000.00 | |
Ending investment: | $5,832.52 | |
Years: | 10.00 |
About Fate Therapeutics |
Fate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of programmed cellular immunotherapies for patients with cancer. Co. is developing cell therapy product candidate. Co.'s off-the-shelf, induced pluripotent stem cells (iPSC) derived cellular immunotherapy pipeline include: FT516, which is an off-the-shelf natural killer (NK) cell cancer immunotherapy derived from a clonal master iPSC line engineered to express a high-affinity, non-cleavable CD16 Fc receptor; and FT596, which is an off-the-shelf chimeric antigen receptor NK cell cancer immunotherapy derived from a clonal engineered master iPSC line. According to our Fate Therapeutics stock split history records, Fate Therapeutics has had 0 splits. |
FATE Split History Table | |
Date | Ratio |
Fate Therapeutics Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.